Reply to letter from Mayfield et al. regarding "Lot variation and inter-device differences contribute to poor analytical performance of the DCA Vantage™ HbA1c POCT instrument in a true clinical setting"

Clin Chem Lab Med. 2022 Oct 26;61(1):e8-e10. doi: 10.1515/cclm-2022-0915. Print 2023 Jan 27.
No abstract available

Keywords: HbA1c; analytical performance; point of care testing.

Publication types

  • Letter
  • Comment

MeSH terms

  • Glycated Hemoglobin / analysis
  • Humans
  • Point-of-Care Systems*

Substances

  • Glycated Hemoglobin A